» Articles » PMID: 19233254

Age-related Changes in Melatonin Synthesis in Rat Extrapineal Tissues

Overview
Journal Exp Gerontol
Specialty Geriatrics
Date 2009 Feb 24
PMID 19233254
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

In the search of new therapeutic targets improving the quality of life of elderly, melatonin, "the chemical expression of darkness", seems to play a remarkable role in aging process possibly due to its antioxidant, immunoenhancer and anti-aging properties. The present study was designed to elucidate effects of aging in melatonin extrapineal synthesis and investigate evident age-related alterations in the action mechanisms involved. The presence of the two key enzymes involved in melatonin synthesis, arylalkylamine-N-acetyltransferase (AA-NAT) and hydroxyindole-O-methyltransferase (HIOMT) was analyzed in thymus, spleen, liver, kidney and heart of 3- and 12month-old rats using real time PCR as well as its functionality by enzymatic activity assays. In addition, extrapineal melatonin content was measured by a competitive enzyme immunoassay (ELISA). The results of this study reveal that all rat tissues studied including thymus, and for the first time, spleen, liver, kidney and heart have the necessary machinery to synthesize melatonin. Moreover, we report an age-related decline in rat extrapineal melatonin synthesis with a consequent HIOMT functionality decrease in spleen, liver and heart during physiological aging. On the contrary, NAT enzymatic activity maintains unchanged without evident alterations with advancing age. Moreover, diminished melatonin concentrations were measured in these tissues cited above during aging except in the thymus, where, surprisingly, melatonin content, NAT/HIOMT expression, and enzymatic functionality assays revealed no significant alterations with age. As a conclusion, we report evident age-related changes in melatonin synthesis in some rat peripheral organs. We suggest that thymus may develop compensatory mechanisms to counteract the loss of immune activity and consequently, the loss of this potent antioxidant, during physiological aging.

Citing Articles

Homeostatic Shrinkage of Dendritic Spines Requires Melatonin Type 3 Receptor Activation During Sleep.

Li S, Li X, Lu M, Chen Q, Yao D, Yu X Adv Sci (Weinh). 2024; 11(38):e2400253.

PMID: 39119847 PMC: 11481193. DOI: 10.1002/advs.202400253.


Determination of Rhythmicity and Gestational Stage-Related Distribution of Blood Plasma Melatonin Concentrations in Donkey Mares.

Harmat L, Nagy J, Somoskoi B, Alpar A, Fekete S, Gaspardy A Vet Sci. 2024; 11(7).

PMID: 39057994 PMC: 11281557. DOI: 10.3390/vetsci11070310.


From Chronodisruption to Sarcopenia: The Therapeutic Potential of Melatonin.

Fernandez-Martinez J, Ramirez-Casas Y, Yang Y, Aranda-Martinez P, Martinez-Ruiz L, Escames G Biomolecules. 2023; 13(12).

PMID: 38136651 PMC: 10741491. DOI: 10.3390/biom13121779.


Study of a First Approach to the Controlled Fermentation for Lambic Beer Production.

Postigo V, Garcia M, Arroyo T Microorganisms. 2023; 11(7).

PMID: 37512854 PMC: 10384975. DOI: 10.3390/microorganisms11071681.


Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders.

Potes Y, Cachan-Vega C, Antuna E, Garcia-Gonzalez C, Menendez-Coto N, Boga J Int J Mol Sci. 2023; 24(5).

PMID: 36902233 PMC: 10002978. DOI: 10.3390/ijms24054803.